Hara Capital’s Gilead Sciences GILD Stock Holding History

Hara Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$410K	Sell	2,940 -65	-2%	-$9.1K	0.2%	100
2025 Q4	$369K	Hold	3,005	–	–	0.21%	100
2025 Q3	$334K	Hold	3,005	–	–	0.2%	97
2025 Q2	$333K	Hold	3,005	–	–	0.21%	97
2025 Q1	$337K	Sell	3,005 -3,005	-50%	-$310K	0.23%	97
2024 Q4	$555K	Buy	6,010 +3,005	+100%	+$271K	0.18%	109
2024 Q3	$252K	Hold	3,005	–	–	0.16%	109
2024 Q2	$206K	Sell	3,005 -10	-0.3%	-$667	0.13%	128
2024 Q1	$221K	Hold	3,015	–	–	0.13%	123
2023 Q4	$244K	Buy	+3,015	New	+$235K	0.17%	110

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Hara Capital's GILD Position: Q1 2026 in Review

Hara Capital reduced its Gilead Sciences (GILD) stake by 2.2% in Q1 2026, selling an estimated $9.1K and leaving 2,940 shares worth $410K. The position accounts for 0.2% of the portfolio, ranked #100.

Hara Capital first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $555K in Q4 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Hara Capital held 2,940 shares of Gilead Sciences worth $410K as of Q1 2026.
Hara Capital sold 65 Gilead Sciences shares in Q1 2026, an estimated $9.1K.
Gilead Sciences made up 0.2% of Hara Capital's portfolio in Q1 2026, its #100 holding.
Hara Capital first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
Hara Capital's Gilead Sciences position peaked at $555K in Q4 2024.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.